Exploring Fatigue and Innovative Treatments in Inflammatory Diseases

This chapter explores the impact of central nervous system factors on fatigue in patients with inflammatory diseases. It also introduces Sonolocumab, a promising new medication for psoriatic arthritis, highlighting its positive results from a phase 2 trial.